Long-term Effects of COVID-19 Vaccines on Children and Removal of Vaccine-differentiated Measures in Medical Facilities

21 Mr Yip Hon Weng asked the Minister for Health (a) what is the total incidence of Multisystem Inflammatory Syndrome in Children who have caught COVID-19 that are (i) vaccinated and (ii) non-vaccinated; and (b) whether the current review of mRNA vaccines by HSA will include the long-term effects of the vaccines on children, particularly with regard to risks of developmental defects in children below five years old.

22 Assoc Prof Jamus Jerome Lim asked the Minister for Health whether resource constraints at our medical facilities and hospitals remain a binding constraint on (i) the full removal of vaccine-differentiated measures (VDMs) and (ii) the consideration to make such VDMs illegal.

23 Mr Yip Hon Weng asked the Minister for Health (a) whether there is an update on HSA's assessment of the use of Novavax COVID-19 vaccine for persons aged 18 and below; and (b) whether there are plans to eventually approve the Novavax COVID-19 vaccine as a non-mRNA vaccine alternative for children aged six months and above.

Mr Ong Ye Kung: These questions have been addressed in my reply to Question Nos 1 and 2 for Oral Answer on the Order Paper for 13 September 2022.